J. Goldman & Co’s Stemline Therapeutics, Inc. STML Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-177,602
| Closed | -$1.89M | – | 300 |
|
2019
Q4 | $1.89M | Sell |
177,602
-380,794
| -68% | -$4.05M | 0.14% | 96 |
|
2019
Q3 | $5.81M | Buy |
+558,396
| New | +$5.81M | 0.44% | 43 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 287 |
|
2019
Q1 | – | Sell |
-225,000
| Closed | -$2.14M | – | 270 |
|
2018
Q4 | $2.14M | Buy |
225,000
+125,000
| +125% | +$1.19M | 0.16% | 93 |
|
2018
Q3 | $1.66M | Hold |
100,000
| – | – | 0.12% | 92 |
|
2018
Q2 | $1.61M | Buy |
100,000
+18,800
| +23% | +$302K | 0.08% | 139 |
|
2018
Q1 | $1.24M | Buy |
81,200
+31,200
| +62% | +$477K | 0.05% | 162 |
|
2017
Q4 | $780K | Sell |
50,000
-51,316
| -51% | -$801K | 0.04% | 145 |
|
2017
Q3 | $1.13M | Sell |
101,316
-18,684
| -16% | -$207K | 0.06% | 131 |
|
2017
Q2 | $1.1M | Sell |
120,000
-20,000
| -14% | -$184K | 0.06% | 121 |
|
2017
Q1 | $1.2M | Sell |
140,000
-59,886
| -30% | -$512K | 0.06% | 140 |
|
2016
Q4 | $2.14M | Buy |
+199,886
| New | +$2.14M | 0.14% | 94 |
|